Jushi (JUSHF) vs. Its Peers Head to Head Review

Jushi (OTCMKTS:JUSHF) is one of 53 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its peers? We will compare Jushi to similar companies based on the strength of its valuation, earnings, risk, dividends, analyst recommendations, institutional ownership and profitability.

Institutional & Insider Ownership

21.7% of Jushi shares are owned by institutional investors. Comparatively, 16.2% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 21.0% of Jushi shares are owned by insiders. Comparatively, 22.5% of shares of all “Medicinals & botanicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Jushi and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jushi	0	2	0	0	2.00
Jushi Competitors	246	546	909	66	2.45

As a group, “Medicinals & botanicals” companies have a potential upside of 75.86%. Given Jushi’s peers stronger consensus rating and higher possible upside, analysts plainly believe Jushi has less favorable growth aspects than its peers.

Profitability

This table compares Jushi and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jushi	-24.16%	-320.66%	-10.31%
Jushi Competitors	-48.57%	-31.53%	-7.91%

Risk & Volatility

Jushi has a beta of -0.16, meaning that its share price is 116% less volatile than the S&P 500. Comparatively, Jushi’s peers have a beta of 1.32, meaning that their average share price is 32% more volatile than the S&P 500.

Earnings and Valuation

This table compares Jushi and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Jushi	$269.45 million	-$65.10 million	-2.13
Jushi Competitors	$325.84 million	-$162.92 million	-10.08

Jushi’s peers have higher revenue, but lower earnings than Jushi. Jushi is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

Jushi peers beat Jushi on 9 of the 13 factors compared.

About Jushi

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.